These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 23870656)
1. Elevated circulating soluble interleukin-2 receptor in patients with non-segmental vitiligo in North American. Shi YL; Li K; Hamzavi I; Lim HW; Zhou L; Mi QS J Dermatol Sci; 2013 Sep; 71(3):212-4. PubMed ID: 23870656 [No Abstract] [Full Text] [Related]
2. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients. Zailaie MZ Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE. Galadari I Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):109-11. PubMed ID: 15918298 [TBL] [Abstract][Full Text] [Related]
4. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients. Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190 [TBL] [Abstract][Full Text] [Related]
5. Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo. Honda Y; Okubo Y; Koga M J Dermatol; 1997 Sep; 24(9):561-3. PubMed ID: 9350100 [TBL] [Abstract][Full Text] [Related]
6. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. Caixia T; Hongwen F; Xiran L J Dermatol Sci; 1999 Sep; 21(1):59-62. PubMed ID: 10468193 [TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo: relationship with type and extent of the disease. Franczuk A; Szepietowski JC; Noworolska A Acta Dermatovenerol Croat; 2004; 12(2):71-6. PubMed ID: 15075040 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Kemp EH; Emhemad S; Akhtar S; Watson PF; Gawkrodger DJ; Weetman AP Exp Dermatol; 2011 Jan; 20(1):35-40. PubMed ID: 21158937 [TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo. Vaccaro M; Cannavò SP; Imbesi S; Cristani M; Barbuzza O; Tigano V; Gangemi S Int J Dermatol; 2015 Jun; 54(6):672-4. PubMed ID: 25427848 [TBL] [Abstract][Full Text] [Related]
10. [Correlation between the serum levels of interleukin-2 and soluble interleukin-2 receptor and the response to immunosuppressive therapy in severe aplastic anemia patients]. Shao Z; Chen K; Chen G; Zhang Y; Wang T; Zou R; Zhou X; Zhou Y; Chu Y Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):180-2. PubMed ID: 15622762 [TBL] [Abstract][Full Text] [Related]
11. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors. Fujita N; Okamoto Y; Gotoh Y; Yada Y; Suzuki Y; Ando T; Togari H; Nishida M Cytokine; 2005 Nov; 32(3-4):143-8. PubMed ID: 16226465 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]. Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038 [TBL] [Abstract][Full Text] [Related]
13. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy. Dejica D Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973 [TBL] [Abstract][Full Text] [Related]
14. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies. Nakase K; Tsuji K; Tamaki S; Tanigawa M; Ikeda T; Miyanishi E; Shiku H Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555 [TBL] [Abstract][Full Text] [Related]
15. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis]. Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592 [TBL] [Abstract][Full Text] [Related]